These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 31206708

  • 21. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.
    Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM.
    Cancer; 2014 Oct 01; 120(19):3082-8. PubMed ID: 24898672
    [Abstract] [Full Text] [Related]

  • 22. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ, Nedzi L, Khan S, Hughes R, Sumer BD, Myers LL, Truelson JM, Koshy M.
    JAMA Otolaryngol Head Neck Surg; 2016 Aug 01; 142(8):777-88. PubMed ID: 27368076
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
    Cramer JD, Ferris RL, Kim S, Duvvuri U.
    Oral Oncol; 2018 Dec 01; 87():170-176. PubMed ID: 30527235
    [Abstract] [Full Text] [Related]

  • 25. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC, Koo BS, Lee JS, Choi EC.
    Laryngoscope; 2006 Jul 01; 116(7):1232-5. PubMed ID: 16826066
    [Abstract] [Full Text] [Related]

  • 26. Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States.
    Stenmark MH, Shumway D, Guo C, Vainshtein J, Mierzwa M, Jagsi R, Griggs JJ, Banerjee M.
    Laryngoscope; 2017 Oct 01; 127(10):2270-2278. PubMed ID: 28304083
    [Abstract] [Full Text] [Related]

  • 27. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
    O'Brien CJ, Traynor SJ, McNeil E, McMahon JD, Chaplin JM.
    Arch Otolaryngol Head Neck Surg; 2000 Mar 01; 126(3):360-5. PubMed ID: 10722009
    [Abstract] [Full Text] [Related]

  • 28. Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Rath TJ, Narayanan S, Hughes MA, Ferris RL, Chiosea SI, Branstetter BF.
    AJNR Am J Neuroradiol; 2017 Jul 01; 38(7):1405-1410. PubMed ID: 28450437
    [Abstract] [Full Text] [Related]

  • 29. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L, Landin D, Haeggblom L, Tertipis N, Grün N, Bersani C, Marklund L, Ghaderi M, Näsman A, Ramqvist T, Nordfors C, Munck-Wikland E, Tani E, Dalianis T.
    Head Neck; 2017 Mar 01; 39(3):419-426. PubMed ID: 27898186
    [Abstract] [Full Text] [Related]

  • 30. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK, Chen YH, Neville BA, Tishler RB, Schoenfeld JD, Catalano PJ, Margalit DN.
    Cancer; 2015 Aug 01; 121(15):2594-602. PubMed ID: 25873094
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Frequency and distributions of cervical lymph node metastases in oropharyngeal squamous cell carcinoma].
    Akashi K, Hayashi R, Shinozaki T, Miyazaki M, Daiko H, Ebihara M.
    Nihon Jibiinkoka Gakkai Kaiho; 2013 Oct 01; 116(10):1100-5. PubMed ID: 24313060
    [Abstract] [Full Text] [Related]

  • 33. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.
    Lee NCJ, Kelly JR, Park HS, Yarbrough WG, Burtness BA, Husain ZA.
    Pract Radiat Oncol; 2017 Oct 01; 7(5):e317-e321. PubMed ID: 28356201
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY, Sinha P, Last A, Ettyreddy A, Kallogjeri D, Pipkorn P, Rich JT, Zevallos JP, Paniello R, Puram SV, Van Abel K, Moore EJ, Oppelt P, Palka K, Adkins D, Daly M, Gay H, Thorstad WL, Jackson RS.
    JAMA Otolaryngol Head Neck Surg; 2021 Jan 01; 147(1):16-22. PubMed ID: 33151273
    [Abstract] [Full Text] [Related]

  • 36. Management of the "violated neck" in the era of chemoradiation.
    Loyo M, Johnson JT, Westra WH, Chiosea SI, Gourin CG.
    Laryngoscope; 2011 Nov 01; 121(11):2349-58. PubMed ID: 21993776
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D, Yabuki K, Arai Y, Tanabe T, Chiba Y, Nishimura G, Takahashi H, Yamanaka S, Oridate N.
    Auris Nasus Larynx; 2018 Jun 01; 45(3):558-565. PubMed ID: 28760331
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.